Heart Failure

Geriatrics addresses the health needs of older adults, focusing on frailty, dementia, falls, and chronic disease management.

Heart Failure: Overview and Definition

Heart Failure (HF) is no longer viewed as a sudden mechanical collapse, but as a chronic, progressive "Syndrome of Cellular Exhaustion." It is a state where the heart muscle either loses its contractile power or its ability to relax and fill. At Liv Hospital, we shift the clinical perspective from merely managing fluid to Biological Repair, addressing the underlying loss of healthy heart tissue through regenerative insights.

The Mechanism of Ventricular Remodeling

When the heart weakens, the body activates survival mechanisms that lead to Ventricular Remodeling a destructive change in the heart's geometry. This process results in wall thinning or pathological thickening, driven by neurohormonal overdrive and the buildup of stiff collagen known as fibrosis.

Regenerative Medicine and the Paracrine Effect

Our approach utilizes the paracrine hypothesis, where biological agents signal the heart to stop scarring and start repairing. By introducing regenerative signals, we aim to inhibit cell death and stimulate angiogenesis (the growth of new blood vessels) to restore oxygen delivery to hibernating heart tissue.

Symptoms and Conditions

The clinical manifestation of heart failure involves a spectrum of symptoms that reflect the heart's inability to meet metabolic demands. Recognizing these signs early is essential for preventing rapid functional decline and metabolic inflexibility within the cardiac cells.

Functional Indicators of Cardiac Stress

• Dyspnea and Congestion: Shortness of breath during activity or rest, often caused by fluid backing up into the lungs.
• Persistent Fatigue: A state of "cellular exhaustion" where the muscles and organs receive insufficient oxygenated blood.
• Peripheral Edema: Significant swelling in the legs, ankles, or abdomen due to systemic fluid retention.

Associated Functional Phenotypes

Heart failure is categorized by the Left Ventricular Ejection Fraction (LVEF). We distinguish between HFrEF (Reduced EF), where the heart is weak and dilated, and HFpEF (Preserved EF), where the heart is stiff and cannot fill properly. Each phenotype requires a unique personalized medicine strategy.

Classification and Functional Phenotypes

To tailor heart failure treatment effectively, we must define the heart's specific "Phenotype." This classification moves beyond a simple diagnosis, focusing on the heart's functional capacity and its ability to pump or fill. At the center of this evaluation is the Left Ventricular Ejection Fraction (LVEF), which measures the percentage of blood the heart pumps out with each beat.

Understanding Ejection Fraction (EF) Categories

• HFrEF (Reduced EF): Systolic failure where the EF is below 40%. The heart is weak and dilated, making it the primary target for ventricular remodeling reversal and cellular therapies.

• HFpEF (Preserved EF): Diastolic failure where the EF is 50% or higher. The heart is stiff and cannot fill properly, requiring focus on reducing fibrosis and improving muscle flexibility.

• HFmrEF (Mildly Reduced EF): A transition zone with an EF between 41% and 49%, representing a "grey area" that requires precise metabolic monitoring and early regenerative signaling.

The Stages of Heart Failure Progression

Heart failure is a spectrum divided into four stages (A through D). Identifying the "Therapeutic Window" is essential; for instance, Stage B (Pre-Heart Failure) is the critical window where structural changes exist without symptoms, allowing for early intervention to preserve the heart's anatomical reserve.

Heart Failure with Reduced Ejection Fraction

Heart Failure with Reduced Ejection Fraction, often referred to as systolic heart failure, occurs when the left ventricle becomes too weak to pump blood effectively to the rest of the body. In this condition, the ejection fraction is 40% or less, meaning the heart is struggling to meet the systemic demands for oxygenated blood. At Liv Hospital, we treat HFrEF as a target for ventricular remodeling reversal, focusing on restoring the heart's contractile strength.

The Pathophysiology of a Weakened Pump

In HFrEF, the heart muscle often becomes thin and dilated, a process driven by chronic neurohormonal overdrive. This structural stretching leads to a loss of "elastic recoil," causing blood to pool in the chambers rather than being ejected. Regenerative insights aim to stop this expansion by addressing the underlying extracellular matrix decay and the loss of healthy cardiomyocytes that define the condition's progression.

Regenerative Targets for Remuscularization

Treatment for HFrEF focuses on biological restoration to improve the heart's "squeeze" and overall efficiency. We utilize therapeutic strategies designed to modulate inflammation and stimulate angiogenesis, providing the necessary blood flow for "hibernating" heart tissue to regain function. The ultimate goal is to improve the ejection fraction and restore the patient's functional independence through targeted cellular rejuvenation.

Diagnosis and Evaluation

A precise evaluation is the cornerstone of effective cardiac care. We utilize advanced diagnostics to identify the "Therapeutic Window," ensuring that interventions are applied before structural damage becomes irreversible.

Technological and Clinical Assessment

• Echocardiography: Mapping the heart's specific phenotype to determine the exact ejection fraction.
• Biochemical Screening: Measuring stress markers like NT-proBNP to quantify the degree of heart strain.
• Cardiac MRI: Evaluating the extracellular matrix to measure the extent of scarring and viable muscle tissue.

The Stages of Progression

We categorize heart failure from Stage A (High Risk) to Stage D (Advanced). Identifying patients in the Pre-Heart Failure stage (Stage B) provides a critical window for preventative regenerative signaling to halt structural decay before symptoms even appear.

Treatment and Care

Our philosophy for treating heart failure is "Active Restoration." We integrate standard medical therapies with cutting-edge biological solutions to rejuvenate the failing heart muscle.

Advanced Biological Interventions

• Modulating Inflammation: Turning off the chronic inflammation that drives tissue scarring.
• Cellular Signaling Therapy: Utilizing growth factors to wake up the heart’s own limited repair cells.
• Neurohormonal Balance: Managing the toxic effects of stress hormones to allow for tissue recovery.

Mechanical and Surgical Support

When conservative and biological methods reach their limit, we transition to advanced surgical solutions. This includes specialized pacing devices or mechanical support, always integrated with a focus on preserving the remaining anatomical reserve of the myocardium.

Wellness and Prevention

Prevention is focused on Epigenetic Prevention managing risk factors today to alter the heart's future. By shielding the heart from unnecessary stress, we can significantly influence its mechanical age.

Pillars of Cardiac Longevity

• Metabolic Mastery: Controlling blood pressure and glucose to prevent the "metabolic exhaustion" of heart cells.
• Cardiovascular Nutrition: Diets rich in antioxidants to reduce oxidative stress in the vascular system.
• Activity Pacing: Utilizing low-impact aerobic exercise to improve cerebral blood flow and cardiac efficiency.

The "Joint-First" Approach to the Heart

Just as in joint health, we emphasize protecting the "cellular substrate" of the heart. Maintaining a healthy weight and avoiding toxins like tobacco are essential "insurance policies" for long-term functional independence.